|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sakuramoto S, Sasako M, Yamaguchi T,
Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi
Y, Imamura H, et al: ACTS-GC Group: Adjuvant chemotherapy for
gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med.
357:1810–1820. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Power DG, Kelsen DP and Shah MA: Advanced
gastric cancer-slow but steady progress. Cancer Treat Rev.
36:384–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park HR, Tomida A, Sato S, Tsukumo Y, Yun
J, Yamori T, Hayakawa Y, Tsuruo T and Shin-ya K: Effect on tumor
cells of blocking survival response to glucose deprivation. J Natl
Cancer Inst. 96:1300–1310. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
The State Pharmacopoeia Commission:
Pharmacopoeia of People's Republic of China. Chin Med Sci Technol
Press; Beijing: pp. 312010
|
|
6
|
Xia WB, Xue Z, Li S, Wang SJ, Yang YC, He
DX, Ran GL, Kong LZ and Shi JG: Chemical constituents from tuber of
Cremastra appendiculata. Zhongguo Zhong Yao Za Zhi. 30:1827–1830.
2005.PubMed/NCBI
|
|
7
|
Feng D, Ma Y, Liu J, Xu L, Zhang Y, Qu J,
Liu Y and Qu X: Cbl-b enhances sensitivity to 5-fluorouracil via
GFR-and mitochondria-mediated pathways in gastric cancercells. Int
J Mol Sci. 14:24399–24411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cory S, Huang DC and Adams JM: The Bcl-2
family: roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo X, Budihardjo I, Zou H, Slaughter C
and Wang X: Bid, a Bcl-2 interacting protein, mediates cytochrome c
release from mitochondria in response to activation of cell surface
death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mathai JP, Germain M and Shore GC:
BH3-only BIK regulates BAX, BAK-dependent release of
Ca2+ from endoplasmic reticulum stores and mitochondrial
apoptosis during stress-induced cell death. J Biol Chem.
280:23829–23836. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan J: Molecular control of life and
death. Curr Opin Cell Biol. 7:211–214. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saraste A and Pulkki K: Morphologic and
biochemical hallmarks of apoptosis. Cardiovasc Res. 45:528–537.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vaux DL and Korsmeyer SJ: Cell death in
development. Cell. 96:245–254. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Antonsson B, Montessuit S, Lauper S, Eskes
R and Martinou JC: Bax oligomerization is required for
channel-forming activity in liposomes and to trigger cytochrome C
release from mitochondria. Biochem J. 345:271–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
O'Neill J, Manion M, Schwartz P and
Hockenbery DM: Promises and challenges of targeting Bcl-2
anti-apoptotic proteins for cancer therapy. Biochim Biophys Acta.
1705:43–51. 2004.PubMed/NCBI
|
|
18
|
Orrenius S: Mitochondrial regulation of
apoptotic cell death. Toxicol Lett. 149:19–23. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin R, Li Z, Zeng J, Lin J and Peng J:
Effect of Pseudobulbus Cremastrae seu Pleiones (EEPCP) on human
gastric carcinoma SGC-7901 cells. Fujian Zhong Yi Yao Da Xue Xue
Bao. 22:22–24. 2012.(In Chinese).
|
|
20
|
Yokosuka T, Goto H, Fujii H, et al: Flow
cytometric chemosensitivity assay using JC 1, a sensor of
mitochondrial transmembrane potential, in acute leukemia. Cancer
Chemother Pharmacol. 72:1335–1342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boos G and Stopper H: Genotoxicity of
several clinically used topoisomerase II inhibitors. Toxicol Lett.
116:7–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen LW, Lin J, Chen W and Zhang W: Effect
of Chinese herbal medicine on patients with primary hepatic
carcinoma in III stage during perioperational period: a report of
42 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:832–834. 2005.(In
Chinese). PubMed/NCBI
|
|
25
|
Chen L, Zheng C and Du J: Study on
antitumor mechanism of Qingre Xiaozheng drink by molecular docking
method. Clin Pharmacol Ther (Chin). 12:324–328. 2007.
|
|
26
|
Cao Z, Lin W, Huang Z, Chen X, Zhao J,
Zheng L, Ye H, Liu Z, Liao L and Du J: Ethyl acetate extraction
from a Chinese herbal formula, Jiedu Xiaozheng Yin, inhibits the
proliferation of hepatocellular carcinoma cells via induction of
G0/G1 phase arrest in vivo and in vitro. Int J Oncol. 42:202–210.
2013.PubMed/NCBI
|
|
27
|
Cao Z, Lin W, Huang Z, Chen X, Zhao J,
Zheng L, Ye H, Liu Z, Liao L and Du J: Jiedu Xiaozheng Yin, a
Chinese herbal formula, inhibits tumor angiogenesis via
downregulation of VEGF-A and VEGFR-2 expression in vivo and in
vitro. Oncol Rep. 29:1080–1086. 2013.PubMed/NCBI
|
|
28
|
Hossini AM and Eberle J: Apoptosis
induction by Bcl-2 proteins independent of the BH3 domain. Biochem
Pharmacol. 76:1612–1619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gabriel B, Sureau F, Casselyn M, Teissié J
and Petit PX: Retroactive pathway involving mitochondria in
electroloaded cytochrome c-induced apoptosis. Protective properties
of Bcl-2 and Bcl-XL. Exp Cell Res. 289:195–210. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
LangRollin I, Maniati M, Jabado O,
Vekrellis K, Papantonis S, Rideout HJ and Stefanis L: Apoptosis and
the conformational change of Bax induced by proteasomal inhibition
of PC12 cells are inhibited by Bcl-xL and Bcl-2. Apoptosis.
10:809–820. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bouaziz C, Martel C, Sharaf el dein O,
Abid-Essefi S, Brenner C, Lemaire C and Bacha H: Fusarial
toxin-induced toxicity in cultured cells and in isolated
mitochondria involves PTPC-dependent activation of the
mitochondrial pathway of apoptosis. Toxicol Sci. 110:363–375. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bras M, Queenan B and Susin SA: Programmed
cell death via mitochondria: Different modes of dying. Biochemistry
(Mosc). 70:231–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
